Hypertrophic scars and keloids in surgery: Current concepts

Annals of Plastic Surgery

Volumn 73, Issue SUPPL.1, 2014, Pages

  Song, Colin ^a  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

ADSCs; dermal replacement; fibroblast; hypertrophic scars; keloids; MSCs; stem cells

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA;

CICATRIX, HYPERTROPHIC; EPIDERMIS; FUNCTIONS OF THE SKIN AND ITS APPENDAGES; HUMAN; KELOID; PATHOLOGY; PHYSIOLOGY; PROCEDURES; SKIN SURGERY;

CICATRIX, HYPERTROPHIC; DERMATOLOGIC SURGICAL PROCEDURES; EPIDERMIS; HUMANS; KELOID; SKIN PHYSIOLOGICAL PHENOMENA; TRANSFORMING GROWTH FACTOR BETA;

EID: 84905982130     PISSN: 01487043     EISSN: 15363708     Source Type: Journal    
DOI: 10.1097/SAP.0000000000000256     Document Type: Conference Paper

References (30)

1. Kischer CW, Brody GS. Structure of the collagen nodule from hypertrophic scars and keloids. Scan Electron Microsc. 1981;3:371-376.
2. Pasyk KA, Argenta LC, Schelbert EB. Angiokeratoma circumscriptum: successful treatment with the argon laser. Ann Plast Surg. 1988;20:183-190.
3. Cohen IK, McCoy BJ, Mohanakumar T, et al. Immunoglobulin, complement, and histocompatibility antigen studies in keloid patients. Plast Reconstr Surg. 1979;63:689-695.
4. Placik OJ, Lewis VL Jr. Immunologic associations of keloids. Surg Gynecol Obstet. 1992;175:185-193.
5. Bloch EF, Hall MG Jr, Denson MJ, et al. General immune reactivity in keloid patients. Plast Reconstr Surg. 1984;73:448-451.
6. Kazeem AA. The immunological aspects of keloid tumor formation. J Surg Oncol. 1988;38:16-18.
7. Yagi KI, Dafalla AA, Osman AA. Does an immune reaction to sebum in wounds cause keloid scars? Beneficial effect of desensitization. Br J Plast Surg. 1979;32:223-225.
8. Fong EP, Bay BH. Keloids: the sebum hypothesis revisited. Med Hypotheses. 2002;58:264-269.
9. Ferguson M, Duncan J, Bond J, et al. Prophylactic administration of avotermin for improvement of skin scarring: three double-blind, placebo-controlled, phase I/II studies. Lancet. 2009;373:1264-1274.
10. Leask A, Abraham DJ. TGF-beta signaling and the fibrotic response. FASEB J. 2004;18:816-827.
11. Rockwell WB, Cohen IK, Ehrlich HP. Keloids and hypertrophic scars: a comprehensive review. Plast Reconstr Surg. 1989;84:827-837.
12. Koonin A. The aetiology of keloids: a review of the literature and a new hypothesis. S Afr Med J. 1964;38:913-916.
13. Shih B, Bayat A. Genetics of keloid scarring. Arch Dermatol Res. 2010;302: 319-339.
14. Berman B. Keloid and Hypertrophic Scar. http://emedicine.medscape.com/ article/1057599.
15. Lim IJ, Phan TT, Song C, et al. Investigation of the influence of keloid-derived keratinocytes on fibroblast growth and proliferation in vitro. Plast Reconstr Surg. 2001;107:797-808.
16. Lim P, Phan TT, Bay BH, et al. Fibroblasts cocultured with keloid keratinocytes: normal fibroblasts secrete collagen in a keloidlike manner. Am J Physiol Cell Physiol. 2002;283:C212-C222.
17. Lim IJ, Phan TT, Aalami O, et al. Smad3 signaling plays an important role in keloid pathogenesis via epithelial-mesenchymal interactions. J Pathol. 2005;207: 232-242.
18. Ong CT, Khoo YT, Tan EK, et al. Epithelial-mesenchymal interactions in keloid pathogenesis modulate vascular endothelial growth factor expression and secretion. J Pathol. 2007;211:95-108.
19. Brusselaers N, Pirayesh A, Hoeksema H, et al. Research review burn scar assessment: a systematic review of different scar scales. J Surg Res. 2010;164: e115-e123.
20. Nguyen DQA, Potokar TS, Price P. An objective long-term evaluation of integra (a dermal skin substitute) and split thickness skin grafts, in acute burns and reconstructive surgery. Burns. 2010;36:23-28.
21. Moiemen NS, Vlachou E, Staiano JJ, et al. Reconstructive surgery with Integra dermal regeneration template: histologic study, clinical evaluation, and current practice. Plast Reconstr Surg. 2006;117:160S-174S.
22. Branski LK, Herndon DN, Pereira C, et al. Longitudinal assessment of Integra in primary burn management: a randomized pediatric clinical trial. Crit Care Med. 2007;35:2615-2623.
23. Ng SW, Shi LM, Song C. Systematic review of dermal substitutes in the treatment of chronic wounds-presented at the 4th biennial meeting of the Wound Healing Society Singapore. 2007.
24. Jones PH, Watt FM. Separation of human epidermal stem cells from transit amplifying cells on the basis of differences in integrin function and expression. Cell. 1993;73:713-247.
25. Li A, Simmons PJ, Kaur P. Identification and isolation of candidate human keratinocyte stem cells based on cell surface phenotype. Proc Natl Acad Sci USA. 1998;95:3902-3907.
26. Lyle S, Christofidou-Solomidou M, Liu Y, et al. The C8/144B monoclonal antibody recognizes cytokeratin 15 and defines the location of human hair follicle stem cells. J Cell Sci. 1998;111:3179-3188.
27. Pellegrini G, Dellambra E, Golisano O, et al. p63 identifies keratinocyte stem cells. Proc Natl Acad Sci USA. 2001;98:3156-3161.
28. Trempus CS, Morris RJ, Bortner CD, et al. Enrichment for living murine keratinocytes from the hair follicle bulge with the cell surface marker CD34. J Invest Dermatol. 2003;120:501-511.
29. Zuk PA, Zhu M, Ashjian P, et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell. 2002;13:4279-4295.
30. Vindigni V, Giatsidis G, Reho F, et al. Chapter 8 Derived Stem Cells: Current State of the Art and Prospective Role in Regenerative Medicine and Tissue Engineering. Andrades JA, ed. Regenerative Medicine and Tissue Engineering.